Epitalon
Also known as: Epithalon, Epithalone, AGAG, Ala-Glu-Asp-Gly
Grey-Market Compound. This compound is not approved by the FDA or any major regulatory authority. No established regimen exists. Products available outside of regulated channels lack standardized manufacturing, quality control, and potency verification. Consult a qualified clinician. Research-only risks apply.
Overview
Clinical Summary
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed to mimic the putative active region of epithalamin, a pineal gland extract studied by Russian gerontologist Vladimir Khavinson. It is primarily investigated for anti-aging properties through proposed telomerase activation. The evidence base is limited, consisting mainly of Russian preclinical studies and small clinical observations. It represents one of the most speculative compounds in the grey-market peptide space.
Plain Language Summary
Epitalon is a small lab-made peptide based on a substance from the pineal gland, studied primarily by Russian researchers for anti-aging purposes. The claim is that it can activate telomerase, an enzyme that helps maintain the protective caps (telomeres) on your chromosomes, potentially slowing aging. The evidence for these claims is very limited, and it is not approved anywhere as a medication. It is one of the more speculative peptides available in the grey market.
Mechanism of Action
The proposed mechanism centers on activation of telomerase, the enzyme that adds telomeric repeats (TTAGGG) to chromosome ends. Telomere shortening is associated with cellular senescence and aging. Epitalon is proposed to stimulate telomerase expression via unclear upstream mechanisms. Additional proposed effects include: regulation of melatonin production from the pineal gland, antioxidant activity, and modulation of gene expression patterns associated with aging. The molecular basis for these effects is not well characterized, and the binding target(s) of the peptide are unknown.
Evidence Summary
Evidence consists primarily of publications from Khavinson's laboratory (Saint Petersburg Institute of Bioregulation and Gerontology). In vitro studies reported telomerase activation in human somatic cells and increased replicative lifespan of fibroblasts. Animal studies in rodents reported increased lifespan and improved physiological parameters with epithalamin/epitalon treatment. A small clinical observational study in elderly patients reported improved melatonin production and immune markers. These findings have not been independently replicated by Western laboratories. The evidence grade is D, reflecting the absence of rigorous, independently replicated human data.
Safety Profile
No significant adverse events have been reported in the limited published literature. However, the safety database is extremely small. Theoretical concerns include unknown effects of telomerase activation (telomerase is upregulated in many cancers), potential effects on pineal function, and unknown long-term consequences. The lack of systematic safety assessment means the risk profile is genuinely unknown.
Contraindications
- Active malignancy (theoretical concern due to telomerase activation)
- Known hypersensitivity
- Pregnancy and breastfeeding
Adverse Events
- Injection site irritation (anecdotal)
- No systematic adverse event data exist
Interactions
- No formal interaction studies
- Theoretical interaction with melatonin supplements
Active Safety Signals
Telomerase is upregulated in approximately 85-90% of human cancers. While epitalon's proposed telomerase activation is positioned as anti-aging, the theoretical concern that promoting telomerase activity could facilitate cancer cell immortalization has not been adequately addressed in the limited available research.
Regulatory Notes
Epitalon is not approved by any regulatory authority worldwide for any indication. It is classified as a research chemical. The Russian Institute of Bioregulation and Gerontology has published extensively but has not pursued Western regulatory approval. Grey-market products vary widely in quality. No established regimen; consult clinician; research-only risks apply.
Monitoring Considerations
No established monitoring protocols. If used, consider: telomere length measurement (limited clinical utility), melatonin levels, immune function markers. General cancer screening may be prudent given the telomerase-activating mechanism.
These are general considerations for clinical awareness and do not constitute prescriptive monitoring recommendations for any individual patient.
Stability and Handling Notes
Small peptide; relatively stable in lyophilized form. Store at -20C to 4C. Grey-market products lack standardized stability data.
References
- 1preclinical
Telomerase Activation by Peptide AEDG (Epitalon)
Khavinson VK, Bondarev IE, Butyugov AA. (2003). Bulletin of Experimental Biology and Medicine
Key findings: Epitalon activated telomerase in human somatic cells and increased replicative lifespan of fibroblasts by 44%.
Limitations: In vitro study. By the development group. Not independently replicated.
- 2preclinical
Effect of Epithalon on Age-Related Changes in Pineal Gland and Brain Function
Anisimov VN, Khavinson VK, et al. (2003). Mechanisms of Ageing and Development
Key findings: Long-term epithalon/epitalon treatment increased lifespan in rodents and improved melatonin production patterns.
Limitations: Rodent study. Not independently replicated. By the primary research group.
Last reviewed: 2024-10-01 | Version: 1 | Status: Published
More in Longevity/Immune
Thymosin Alpha-1
Ta1 · Thymalfasin · Zadaxin
Thymosin alpha-1 is a peptide naturally produced by your thymus gland, which is important for immune function. A synthetic version called Zadaxin is approved in many countries around the world (but not the US) for treating hepatitis B and boosting the immune system. It is one of the most well-studied peptides available, with thousands of published research papers. Some people use it for general immune support and longevity purposes.
MOTS-c
Mitochondrial ORF of the 12S rRNA type-c
MOTS-c is a naturally occurring peptide produced by your mitochondria (the energy factories in your cells). It acts like an exercise signal, helping your body use sugar more efficiently and improving insulin sensitivity. Levels of MOTS-c naturally decrease as you age. A small human study showed that daily injections improved how the body handles insulin in obese men. It is still very early in research and is only available through grey-market sources.
Humanin
HN · HNG (S14G-humanin) · [Gly14]-Humanin
Humanin is a naturally occurring peptide made by your mitochondria that protects cells from dying. It was discovered through Alzheimer disease research, where it was found to prevent brain cell death. Studies in animals suggest it could protect the heart, brain, and metabolic systems. Humanin levels naturally drop as you age. While promising in laboratory studies, it has not been tested in human clinical trials and remains a research-only compound.
Want to discuss this compound with a qualified physician?
The Peptide Association has verified over 160 licensed providers specializing in peptide therapy, with telehealth options available in most states.
Find a Verified Provider